Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Applied in Xiaomi Yeelight’s Smart Lamp
Seoul Semiconductor, a global innovator of LED products and technology, announces that its SunLike Series natural spectrum LEDs, which implement light that closely matches the spectrum of natural sunlight, continues to expand its global application base. Seoul Semiconductor announced that Yeelight, a leader in the intelligent lighting industry and part of Xiaomi’s ecosystem, has adopted Seoul Semiconductor’s SunLike Series natural spectrum LEDs as a light source for its Yeelight LED Desklamp Pro, a lamp that provides adjustable control of study hours, light colors and brightness control (dimming) via its smartphone application, and is compatible with both Amazon Alexa and Google Assistant applications.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180314005383/en/
Yeelight LED Desklamp Pro features Seoul Semiconductor's SunLike Series natural spectrum LED technology. (Photo: Business Wire)
Yeelight’s LED Desklap Pro was designed for an ambitious launch into the global smart desk lamp industry by the company, which has a management philosophy of innovating lighting interaction to deliver the most comfortable light through superior technology. Combining Yeelight’s state-of-the-art application control system and Seoul Semiconductor’s SunLike natural spectrum LED technology, consumers can experience light that closely matches the spectrum of natural sunlight.
Yeelight’s LED Desklamp Pro features user-controllable light modes for intensive studying, as well for vision protection. Equipped with Yeelight's scientific vision protection and study time setting programs, the lamps enable consumers to control these settings through a dedicated mobile phone application, and supports major smart home systems, such as Amazon Alexa and Google Assistant.
Through the use of a pulse width modulation (PWM) filter circuit for the analog signal module, the Desklamp Pro effectively controls light flickering, which relieves eye fatigue and may reduce the incidence of myopia (near-sightedness), which occurs more frequently in children who are not exposed to sunlight for extended periods of time.
Yeelight CEO Jiang Zhaoning, explained, "Yeelight has been leading the market by actively developing innovative lighting systems in partnership with leading partners around the world to provide the most comfortable and relaxing lighting products to consumers. We strive to provide consumers with the safest and healthiest light by working together with Seoul Semiconductor, the innovator of SunLike LED technology, which implements light that closely matches the spectrum of natural sunlight. We believe that thousands of people will experience this differentiated light source with the Smart Desklamp Pro that combines these two companies’ leading technologies."
Caleb Won, executive VP of global marketing group at Seoul Semiconductor, said, “Conventional LED desk lamps currently being used in homes can have potentially negative effects on children's eye health through prolonged exposure to excessive amounts of blue light at certain wavelengths. SunLike Series natural spectrum LEDs represent the next generation natural light LED technology that has achieved the highest level of eye safety certification from the International Commission on Illumination, recognizing SunLike LEDs as an RG-1 level light source with no photo-biological risks. While various attempts have been made to reduce blue light to protect eyesight (such as installing a lens cover), they did not provide a fundamental solution. By implementing light that closely matches the spectrum of natural sunlight, SunLike Series LEDs are an ideal solution to enhance children's eye health and contribute to an optimal learning environment."
Prolonged exposure to excessive blue light can disrupt sleep patterns and has the potential to negatively effect eyesight, because the retinal cell that detect light in the blue wavelength comprise only 5.7% of all human retinal cells. SunLike LED technology, however, implements light with a spectrum that closely matches natural sunlight, providing children with the healthiest and most comfortable light, improving their environment for learning, reducing eye fatigue, and displaying colors and textures more accurately.
SunLike Series natural spectrum LEDs were co-developed by Seoul Semiconductor and Toshiba Materials. They combine Seoul Semiconductor’s optical semiconductor technology and Toshiba Materials’ TRI-R Technology that produces light closer to the spectrum of natural sunlight.
About TRI-R technology
TRI-R® is a natural light LED source technology that reproduces the spectrum of natural sunlight, developed by the concept and spectrum technology of natural light. TRI-R is a registered trademark of Toshiba Material Co., Ltd.
Yeelight, incubated by SOSVenture and made part of Xiaomi ecosystem in 2014, is an innovative leader dedicated to smart lighting applications. Working actively with Amazon, Google and Microsoft, Yeelight delivers the best lighting experience for a smart home.
Under the brands Xiaomi and Yeelight, Yeelight has produced dozens of smart lighting products, with more than 3 million connected lighting products shipped around the world. Yeelight works actively to integrate cutting-edge technology with distinctive designs. Their products incorporate the latest technologies, including AI ready, Wi-Fi enabled, and remote control to enable multiple smart features in the home.
Yeelight products have won international design awards, recognized with the IF Design Award 2017, Reddot Award 2017, IF Gold Design Award, and Good Design Award.
For more information about Yeelight, please visit www.yeelight.com.
About Seoul Semiconductor:
Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; NanoDriver Series – the world’s smallest 24W DC LED Drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, includes all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC.
For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com
WICOP and Acrich are trademarks of Seoul Semiconductor Co., Ltd.
Seoul Semiconductor Europe GmbH
Seoul Semiconductor Inc.
Tel: +1 (901) 831-6614
Seoul Semiconductor Co., Ltd
Tel: +82 070.4391.8270
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Pioneering Project for Pharmaceutics – Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science26.5.2019 10:00:00 EEST | Tiedote
Nanopharmaceutics promises ground-breaking innovation in the development of medicines: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190526005014/en/ The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the University of Basel The commitment by Vifor Pharma and the University of Basel is aimed at ensuring Switzerland has the specialist knowledge and equipment needed to compete globally in this important emerging area of life sciences With this decision, Vifor Pharma is demonstrating its commitment to Switzerland as a world-leading location for pharmaceutical research and development Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with a view to targeting their effect even more precisely. Nanopharmacy therefore promises to help advance medic
XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 21:20:00 EEST | Tiedote
On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p
Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 17:00:00 EEST | Tiedote
Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo
Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 13:20:00 EEST | Tiedote
Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with
New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 08:00:00 EEST | Tiedote
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of
The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 04:00:00 EEST | Tiedote
For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme